Join CRST: The Podcast at the intersection of patient care and innovation in ophthalmology and listen as experts in the field engage in thought-provoking discussion on anterior segment surgery. This podcast curates content and mini series that help progressive cataract and refractive surgeons take their practices to the next level. CRST: The Podcast is produced by Bryn Mawr Communications and the medical trade publication Cataract & Refractive Surgery Today.

CRST: The Podcast
Claim This Podcastby Cataract and Refractive Surgery Today
Podcast Authority
Beta
Podcast Overview
Join CRST: The Podcast at the intersection of patient care and innovation in ophthalmology and listen as experts in the field engage in thought-provoking discussion on anterior segment surgery. This podcast curates content and mini series that help progressive cataract and refractive surgeons take their practices to the next level. CRST: The Podcast is produced by Bryn Mawr Communications and the medical trade publication Cataract & Refractive Surgery Today.
Language
🇺🇲
Publishing Since
6/26/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for CRST: The Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 4, 2026
Refractive Lens Exchange and the Evolving Surgical Management of Presbyopia
George O. Waring IV, MD, FACS, interviews Dagny C. Zhu, MD, exploring her efficient same-day bilateral refractive lens exchange workflow for presbyopia management in an office-based setting.

June 3, 2026
Rethinking the Drop with iDose TR: Patient Access
I. Paul Singh, MD, interviews Deborah Ristvedt, DO, and Kevin Talbot, MD, about optimizing patient access and reimbursement for the interventional glaucoma treatment iDose TR.

May 29, 2026
Vision Correction in Complex Corneas
Neda Shamie, MD, and Neda Nikpoor, MD, interview Eva Kim, MD, discussing vision correction strategies for complex corneas and the evolving role of CXL.
161 total episodes available with 12 transcripts
Recent guests on CRST: The Podcast
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dagny C Zhu
Guest
Deborah Ristvedt
Guest
Kevin Talbot
Guest
Eva Kim
Guest
Susan DeGroot MBA
Guest
Vivian Cole BA
Guest
George O Waring IV MD FACS
Guest
Darrell White MD
Guest
John A Hovanesian MD
Guest
Mark Lobanoff
Guest
Dagny Zhu
Guest
Vance Thompson
Guest
Similar Podcasts
Discover related shows you might enjoy

Ophthalmology off the Grid by Eyetube
Eyetube

Cataract Coach with Uday Devgan MD
Cataract Coach with Uday Devgan MD

Experts InSight
American Academy of Ophthalmology

Ophthalmology Journal
American Academy of Ophthalmology

Eyewire News: The Podcast
Eyewire News

Barron's Streetwise
Barron's

Freakonomics Radio
Freakonomics Radio + Stitcher

SmartLess
Jason Bateman, Sean Hayes, Will Arnett
Deep-dive analytics for CRST: The Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is CRST: The Podcast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.